阿科拉米迪斯对ATTR-CM中复发性和累积性心血管结果的影响:来自ATTRibute-CM的探索性分析
Ahmad Masri1, Daniel P Judge2, Frederick L Ruberg3
1Oregon Health and Science University, Portland, Oregon, USA.
Journal of the American College of Cardiology
|October 27, 2025
概括
在30个月的时间里,阿科拉米迪斯显著降低了 transthyretin amyloid心肌病 (ATTR-CM) 中心血管事件的累积负担. 使用阿科拉米迪斯的早期干预至关重要,因为近四分之一的事件发生在前六个月内.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学 是一个学科.
- 临床试验 临床试验
背景情况:
- 晶氨基氨基酸心肌病 (ATTR-CM) 呈现出重复性心血管 (CV) 事件的高负担.
- 通过口服治疗的阿科拉米迪斯有效地稳定了TTR.
- 以前的研究表明,在ATTR-CM.中,阿科拉米迪斯降低了死亡率或首次CV住院 (CVH) 的复合率.
研究的目的:
- 对阿科拉米迪斯对累积CV结果的疗效进行后期探索性复发事件分析.
- 评估阿科拉米迪斯对ATTR-CM患者复发性CV事件发生率的影响.
主要方法:
- 用一个修改后的安德森-吉尔模型来分析心脏病相关死亡率 (CVM) 或复发性心脏病死亡率的累积发病率.
- 分析包括从ATTRibute-CM研究中修改的治疗意图人口及其开放式扩展.
- 对于CVM或复发性CVH,事件数据被评估到30个月,对于CVM,评估到42个月.
主要成果:
- 通过30个月,阿科拉米迪斯显著降低了CVM或复发性CVH的累积风险,降低了49% (HR:0.51;P < 0.0001).
- 相当一部分CV事件 (19-22%) 发生在前六个月内.
- 到30个月,与安慰剂相比,阿科拉米迪斯在每100名参与者中显示出53次避免事件,持续治疗在42个月后降低了CVM (HR:0.55;P = 0.0011).
结论:
- 阿科拉米迪斯在30个月的ATTR-CM中显著降低了心血管结局的累积负担.
- CV 事件的早期发生凸显了及时诊断和治疗启动的重要性.
- 这些发现强调了阿科拉米迪斯在管理ATTR-CM的渐进性质方面的好处.
更多相关视频
03:40Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
Published on: December 20, 2024
1.3K
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
24.7K
相关概念视频
01:30Acute Coronary Syndrome III: Diagnostic Studies
207
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
207
01:30Acute Coronary Syndrome I: Introduction
785
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
785
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
347
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
347
01:26Atherosclerosis III: Management
312
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
312
01:26Coronary Artery Disease IV: Preventive Measures
580
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
580
01:21Rheumatic Heart Disease III: Medical Management
278
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
278